Doctor Patricia Sansilvestri-Morel

Doctor Patricia Sansilvestri-Morel

Servier Research Institute, Suresnes (France)

phD in Hematology/ Cellular and Molecular Biology (France) Project Director in Cardiovascular & Metabolic Diseases Research Servier Research Institute

Presentations

S62798, a TAFIa inhibitor, accelerates endogenous thrombolysis in a murine model of pulmonary thromboembolism

Event: ESC Congress 2020

Topic: Anticoagulants

Session: Antithrombotic Therapy Update

Access

ESC 365 is supported by

Explore sponsored resources

Doctor Patricia Sansilvestri-Morel

Biography

Contributor content

S62798, a TAFIa inhibitor, accelerates endogenous thrombolysis in a murine model of pulmonary thromboembolism

ESC 365 is supported by

Doctor Patricia Sansilvestri-Morel Follow

Biography

Contributor content

S62798, a TAFIa inhibitor, accelerates endogenous thrombolysis in a murine model of pulmonary thromboembolism

ESC 365 is supported by

Doctor Patricia Sansilvestri-Morel